Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Tele-SSM: A Telephone Technology Innovation in the Intervention on Supported Self-management for Depression in Vietnam [NA]
This completed clinical trial in Vietnam evaluated Tele-SSM, a telephone-based intervention to support self-management for depression. The s…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Digital Therapeutic for Depression After Head Injury in Current and Former US Military Personnel [NA]
This clinical trial update describes a digital therapeutic aimed at depressive symptoms following mild traumatic brain injury in current and…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Evaluation of Caregiver Burden and Depression Severity in Patients With Hemiplegia
This clinical trial update confirms the completion of a study evaluating caregiver burden and depression severity in patients with hemiplegi…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive Symptoms [NA]
This clinical trial is recruiting to compare traditional Buddhist mindfulness training with secular mindfulness-based cognitive therapy in a…
-
FDA label_change · 2024-06-12FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE submitted by Zydus Lifesciences Limited, resulting in changes to the pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Self-guided Treatment for Adolescents Navigating Depression [NA]
Completed a clinical trial evaluating a self-guided treatment for adolescents with depressive symptoms and depression. Results were posted o…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: HypErthermia as an Additional Treatment for the Biology and Experience of Depression [NA]
The study evaluating hyperthermia as an adjunctive treatment for Major Depressive Disorder has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms [NA]
A completed study using combined N-of-1 trials to evaluate open-label placebo treatment for antidepressant discontinuation symptoms in indiv…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: The Taste-Mood Diagnostic Study [NA]
Ranvier Health Ltd's Taste-Mood Diagnostic Study for depression is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Patient Characteristics and Cognitive vs. Behavioral Therapies for Depression [NA]
This clinical trial update describes patient characteristics and compares cognitive therapy to behavioral therapy for Major Depressive Disor…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems [NA]
An update on a clinical trial studying a parent-child single-session growth mindset intervention for adolescent depression and anxiety, spon…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial [NA]
The MOTIVE feasibility trial for multiparas addressing fear of childbirth through intervention has completed, evaluating intervention strate…
-
CLINICAL_TRIALS withdrawal · 2024-06-11Clinical Trial Update: Creatine for Treatment of Depression Associated With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating creatine for depression in patients with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Whole-body Hyperthermia for Depression [NA]
This University of Zurich study is evaluating whole-body hyperthermia as a treatment for Major Depressive Disorder and is currently in the r…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Amygdala and dLPFC MRI-TIS for Depression in Adolescents [NA]
A clinical trial is recruiting adolescents with major depressive disorder to study MRI-based stimulation targeting the amygdala and dorsolat…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Psilocybin-assisted Therapy for Alcohol Use Disorder [Phase 2]
Phase 2 clinical trial evaluating psilocybin-assisted therapy for alcohol use disorder is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Interest of Animal-assisted Therapy With Dogs in the Treatment of Depression [NA]
This clinical trial update describes an investigation into animal-assisted therapy with dogs for depression; the study is currently not yet …
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics [NA]
A clinical trial update describing a stepped-care program for obstetrics and gynecology clinics addressing depression, with the study comple…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Effects of Crossover Point Exercise on Depression, Anxiety and Stress in Chinese Postmenopausal Women [NA]
Overview of a trial evaluating whether crossover point exercise reduces depression, anxiety and stress in Chinese postmenopausal women. The …
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents [NA]
Clinical trial results for Goal2QuitVaping, a program aimed at helping adolescents quit nicotine vaping, including considerations related to…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine [Phase 1]
Phase 1 study evaluating (2R,6R)-Hydroxynorketamine for major depressive disorder has completed with results posted.
-
FDA approval · 2024-06-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' Venlafaxine hydrochloride as an original-application generic (ANDA 217767). Venlafaxine HCl is indicat…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Integrated Depression Care [NA]
A clinical trial at Ghent University is recruiting to evaluate integrated depression care for mild, moderate, and severe major depressive di…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment [NA]
A clinical trial from Shanghai Mental Health Center is evaluating EEG-based precise repetitive transcranial magnetic stimulation for Major D…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Chatbot-based Mindfulness Programme for Depressive University Students: Pilot Intervention Study [NA]
This document reports the completion of a pilot trial evaluating a chatbot-based mindfulness program for depressive symptoms in university s…